Norges Bank Athenex, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 09, 2018	SELL	$14.41 - $19.15 $1.08 Million - $1.44 Million	-75,000 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$13.5 - $19.51 $1.01 Million - $1.46 Million	75,000 New	75,000 $1.31 Million
Q3 2017 Nov 07, 2017	SELL	$13.5 - $19.51 $1.01 Million - $1.46 Million	-75,000 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	75,000	75,000 $1.2 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.